X
Xiaoshan Bi
Researcher at Anhui University
Publications - 3
Citations - 1169
Xiaoshan Bi is an academic researcher from Anhui University. The author has contributed to research in topics: Epitope & Coronavirus. The author has an hindex of 2, co-authored 3 publications receiving 748 citations. Previous affiliations of Xiaoshan Bi include Chinese Academy of Sciences.
Papers
More filters
Journal ArticleDOI
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.
Rui Shi,Chao Shan,Xiaomin Duan,Zhihai Chen,Peipei Liu,Jin-Wen Song,Tao Song,Tao Song,Xiaoshan Bi,Xiaoshan Bi,Chao Han,Lianao Wu,Lianao Wu,Ge Gao,Xue Hu,Ya-Nan Zhang,Zhou Tong,Weijin Huang,William J. Liu,Guizhen Wu,Bo Zhang,Lan Wang,Jianxun Qi,Hui Feng,Fu-Sheng Wang,Qihui Wang,George F. Gao,Zhiming Yuan,Jinghua Yan +28 more
TL;DR: Two monoclonal antibodies isolated from a patient with COVID-19 are shown to interfere with SARS-CoV-2–receptor binding, and one displays potent action against this virus in vitro and in a rhesus macaque model.
Journal ArticleDOI
The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
Rui Shi,Yan Chai,Xiaomin Duan,Xiaoshan Bi,Xiaoshan Bi,Qingrui Huang,Qihui Wang,Shuguang Tan,George F. Gao,Jianhua Zhu,Jinghua Yan +10 more
TL;DR: The findings indicate that h4C1 represents a potential therapeutic mAb for lymphoma, and identifies a CD47-targeting mAb that enhanced macrophage-mediated phagocytosis capacity and tumor suppression efficacy in a mouse model.
Journal ArticleDOI
Identification of a hotspot on PD-L1 for pH-dependent binding by monoclonal antibodies for tumor therapy
Hongchuan Liu,Xiaoshan Bi,Xiaoshan Bi,Yuehua Zhou,Rui Shi,Sheng Yao,Jianxun Qi,Hui Feng,Meiqing Feng,Jinghua Yan,Jinghua Yan,Shuguang Tan,Shuguang Tan +12 more
TL;DR: The binding properties of a PD-L1 specific antibody JS003 with tumor suppression potency and the ability of JS003 to promote T cell reactivity in vitro was investigated and revealed that JS003 has substantially enhanced the allogeneic T cell response as measured by IL-2 and IFN-γ secretion.